Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Net Income towards Common Stockholders (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Net Income towards Common Stockholders for 13 consecutive years, with -$543000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 171.92% year-over-year to -$543000.0, compared with a TTM value of -$204.7 million through Dec 2025, down 113.18%, and an annual FY2025 reading of -$204.7 million, down 113.18% over the prior year.
  • Net Income towards Common Stockholders was -$543000.0 for Q4 2025 at Tandem Diabetes Care, up from -$21.2 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $10.8 million in Q4 2021 and bottomed at -$130.6 million in Q1 2025.
  • Average Net Income towards Common Stockholders over 5 years is -$30.1 million, with a median of -$22.2 million recorded in 2024.
  • The sharpest move saw Net Income towards Common Stockholders skyrocketed 161.59% in 2021, then crashed 944.82% in 2022.
  • Year by year, Net Income towards Common Stockholders stood at $10.8 million in 2021, then tumbled by 247.06% to -$15.9 million in 2022, then crashed by 88.82% to -$30.0 million in 2023, then soared by 102.52% to $755000.0 in 2024, then crashed by 171.92% to -$543000.0 in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for TNDM at -$543000.0 in Q4 2025, -$21.2 million in Q3 2025, and -$52.4 million in Q2 2025.